Series D - Neuromed Pharmaceuticals - Mar 8, 2006 Funding Round Profile - Cointime

Bitcoin $94,247.48 -3.81%
Ethereum $3,448.56 +2.76%
BNB $643.18 -2.57%
Optimism $2.34 +7.64%
Arbitrum $0.91 +6.48%
Solana $237.52 -5.63%
Polygon $0.55 -1.46%
Cosmos $8.06 -4.89%
Avalanche $42.23 +1.77%

Bitcoin $94,247.48 -3.81%
Ethereum $3,448.56 +2.76%
BNB $643.18 -2.57%
Optimism $2.34 +7.64%
Arbitrum $0.91 +6.48%
Solana $237.52 -5.63%
Polygon $0.55 -1.46%
Cosmos $8.06 -4.89%
Avalanche $42.23 +1.77%

Neuromed Pharmaceuticals

company

Funding Round

Series D

Money Raised

$ 25M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Cogene Ventures	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Nov 4, 2003	Series C	$ 32M	Cogene Ventures	Detail